These models of AD have been used to explore various aspects of its pathophysiology, ranging from Aβ metabolism and amyloid deposition to the effect of APOE genotype as well as tau and NFT pathology (Götz et al., 2004). The gene discussed is MAPT; the disease is Alzheimer disease.